tirzepatide vs glp-1 Semaglutide vs. Tirzepatide: Which Wins? π₯ Your Guide to the
Description
Appetite Control & Craving Reduction
More randomized data will be required to arrive at conclusive evidence.
Then came the duals (like #tirzepatide), and even triagonists (#retatrutide) that pushed weight loss even farther
A study of 42,000 adults found increased rates of hypotension events after starting GLP-1s
Learn more
Aims/hypothesis Tirzepatide is a novel dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) currently under review for marketing approval
